Click Here For COVID-19 (Coronavirus) Studies

Trials Offered by a Specific Doctor

HERBERT IRVING COMPREHENSIVE CANCER CENTER
Investigator
Susan Bates, MD
Phone
1 212 305 9422
Email
seb2227@cumc.columbia.edu
(Biography not available)

Clinical Studies Managed By Dr. Bates:
More InfoTitleSponsorIRB Number
Details[CLOSED] A study for patients with stage IV untreated Pancreatic cancer using study drug PEGPH20HalozymeAAAQ5851
Details[CLOSED] Study of Extended Chemotherapy vs. Chemotherapy + Radiation Therapy for Adenocarcinoma of the PancreasNCIAAAR3715
Details[CLOSED] Study of Drug in Patients with Previously Treated Bile Duct Cancer (Cholangiocarcinoma)Agios PharmaceuticalsAAAR5645
DetailsStudy of Stimulation with Bethanechol in Pancreatic Adenocarcinoma Prior to SurgeryAmerican Association for Cancer ResearchAAAR6735
Details[CLOSED] A Study of Atezolizumab in Combination with Cobimetinib Versus Atezolizumab Monotherapy in Participants with Unresectable CholangiocarcinomaNIHAAAR9166